Results 81 to 90 of about 64,328 (314)

Role of Salbutamol in The Management of Transient Tachypnea of the Newborn: A Comparative Prospective Study

open access: yesPakistan Armed Forces Medical Journal, 2022
Objective: To compare the outcome of Salbutamol nebulization with normal saline (placebo) in transient tachypnea of the newborn. Study Design: Comparative prospective study.
Waqas Ahmed   +5 more
doaj   +1 more source

Nebuliser therapy in the intensive care unit [PDF]

open access: yes, 1997
The relationship between identity, lived experience, sexual practices and the language through which these are conveyed has been widely debated in sexuality literature.
A Brah   +59 more
core   +4 more sources

Differential pulse voltammetric determination of salbutamol sulfate in syrup pharmaceutical formulation using poly(4-amino-3-hydroxynaphthalene sulfonic acid) modified glassy carbon electrode

open access: yesHeliyon, 2017
A new method for determination of salbutamol sulfate has been developed using poly(4-amino-3-hydroxynaphthalene sulfonic acid/GCE. Cyclic voltammetric investigation of the electrochemical behavior of salbutamol sulfate at the polymer modified glassy ...
Meareg Amare, Getahun Menkir
doaj  

Does inhaled salbutamol before surfactant therapy have any beneficial effect?

open access: yesThe Turkish Journal of Pediatrics, 2018
Beta (β)2 adrenergic receptors are present in alveolar type II cells. Previously, the beneficial effects of inhaled salbutamol treatment on respiratory outcomes were shown in premature infants with transient tachypnea of the newborn.
H Tolga Çelik   +3 more
doaj   +1 more source

Response to salbutamol by wheezy infants [PDF]

open access: yesArchives of Disease in Childhood, 2004
We previously reported a randomised controlled trial of β2 agonist in wheezing infants.1 Within this paper we reported no measurable physiological response to 400 μg salbutamol. Pulmonary function tests were performed after the completion of a symptom diary study and prior to enrolment in a study of inhaled corticosteroid.2 Raw values of maximum flow ...
P Seddon, R J P G Chavasse
openaire   +2 more sources

Anti-Inflammatory Effects of β2-Receptor Agonists Salbutamol and Terbutaline Are Mediated by MKP-1

open access: yesPLoS ONE, 2016
Mitogen-activated protein kinase phosphatase 1 (MKP-1) expression is induced by inflammatory factors, and it is an endogenous suppressor of inflammatory response. MKP-1 expression is increased by PDE4 inhibitor rolipram suggesting that it is regulated by
T. Keränen   +4 more
semanticscholar   +1 more source

Home nebulizer therapy in children [PDF]

open access: yes, 1994
Drug administration in children is never easy especially in those under five years of age. This is even more so in the case of prophylactic inhalational treatment of asthma in children. The role of home nebulizer therapy is reviewed.
Lenicker, Herbert Manfred   +1 more
core  

Evidence for the existence of powder sub-populations in micronized materials : Aerodynamic size-fractions of aerosolized powders possess distinct physicochemical properties [PDF]

open access: yes, 2014
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.Purpose: To investigate the ...
AHL Chow   +61 more
core   +1 more source

An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation

open access: yesActa Pharmaceutica Sinica B, 2014
An aerosol formulation containing 7.5 mg of R-salbutamol sulfate was developed. The aerosol was nebulized with an air-jet nebulizer, and further assessed according to the new European Medicines Agency (EMA) guidelines.
Xuemei Zhang   +4 more
doaj   +1 more source

Dupilumab Efficacy and Safety in Patients With Persistent Asthma: Asia–Pacific Region

open access: yesClinical &Experimental Allergy, EarlyView.
Asthma prevalence is increasing in the Asia–Pacific region, and this population is frequently underrepresented in phase 3 clinical studies. We demonstrate Dupilumab's efficacy and safety among patients with uncontrolled moderate‐to‐severe type 2 asthma.
Qingling Zhang   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy